Talcum Powder Cancer Lawsuit

Ovarian Cancer May Be Too Rare To Conduct An Adequate Study

Talcum powder contains dangerous elongated fibers and also asbestos that can lacerate delicate tissue and cause infection and cancer

Friday, January 22, 2021 - Ovarian cancer talcum powder studies indicate that there is a link between the two. Prominent studies by the American Cancer Society and the other by independent researchers indicate a 30% increased chance and a 24% increased chance respectively. The ACS study notes that it is difficult to query a group of subjects large enough since ovarian cancer as a percentage of the overall population is rare. Johnson & Johnson defends against ovarian cancer talcum powder lawsuits by citing a study that claims there is no direct correlation between using talcum powder and ovarian cancer. Although that study was the largest ever, combining the data from several other studies, a small amount used talcum powder for feminine hygiene, and only a tiny fraction had ovarian cancer.

Scientists agree that using talc for dryness and fragrance immediately after showering on one's genital area may cause particles of talc to enter the vagina, travel up through the Fallopian tubes, and become permanently lodged in the ovaries. Biopsies of cancer ovarian tissues from women who had died from the disease have found particles of talc embedded in the cancerous tissue. Other ways the female reproductive tract can be exposed to talc is via contraceptive diaphragms and condoms that have been dusted with talc. The talcum powder mixtures contain dangerous elongated fibers and also asbestos fibers that can lacerate the delicate tissue and create bleeding and irritation that leads to infection and cancer. Juries from coast to coast agree with this assessment of the dangers of talc and have awarded women with ovarian cancer and the estates of those who have died from the disease, billions of dollars in compensatory and punitive damages.

The National Institute of Health has published scientific papers where studies concluded that there was a cancer risk to using talcum powder. "Talc, like asbestos, is a silicate that has been studied in relation to cancer risk. Several studies conducted over the past 25 years found an association between perineal talc powders and ovarian cancer," according to the NIH. The ACS points out that women who use talc on their genitals have an increased ovarian cancer risk.

"Prospective cohort studies, which would not have the same type of potential bias, have generally not found a significant increase in ovarian cancer risk overall. However, some have suggested possible increased risks in certain groups of women (for example, in women who still have an intact reproductive tract) or in certain types of ovarian cancer."

There are currently over 25,000 female plaintiffs with ovarian cancer and many more men and women with mesothelioma that have filed lawsuits alleging talcum powder manufacturer Johnson & Johnson failed to warn them about the talcum powder ovarian cancer relationship. Johnson's Baby Powder Cancer Lawyers are interviewing potential clients that have suffered injury from using the product.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.